<DOC>
	<DOCNO>NCT00919958</DOCNO>
	<brief_summary>The The purpose study determine safety PLX-PAD single dose , Intra-muscular injection treatment CLI patient .</brief_summary>
	<brief_title>Safety Intramuscular Injection Allogeneic PLX-PAD Cells Treatment Critical Limb Ischemia</brief_title>
	<detailed_description>PLX-PAD mesenchymal-like stromal cell derive full term placenta , term PLX-PAD , intend treatment Critical Limb Ischemia</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>1 . Diagnosis critical limb ischemia define persistent , recur ischemic rest pain least two ( 2 ) week , and/or ulceration gangrene foot toe , ABI &lt; 0.4 or/and TBI &lt; 0.4 transcutaneous partial pressure oxygen â‰¤ 30 mmHg pO2 foot . 2 . Rutherford category 45 3 . No acceptable option revascularisation confirm angiographic imaging result color flow duplex ultrasound obtain within 6 month prior screen visit sign approval vascular surgeon . 4 . In opinion investigator , major amputation anticipate period three ( 3 ) month . 1 . Uncontrolled hypertension ( define diastolic blood pressure &gt; 110 mmHg systolic blood pressure &gt; 180 mmHg screening ) . 2 . Poorly control diabetes mellitus ( HbA1c &gt; 9 % ) 3 . Wounds severity great Grade 2 Wagner Scale 4 . Lifethreatening ventricular arrhythmia except ICD implant unstable angina pectoris characterize increasingly frequent episode modest exertion rest , worsen severity , prolong 5 . ST segment elevation myocardial infarction and/or TIA/CVA within six ( 6 ) month prior enrollment . Patients severe congestive heart failure ( i.e . NYHA Stage IV ) 6 . In opinion investigator , patient unsuitable cellular therapy .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>81 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Critical limb ischemia</keyword>
</DOC>